Ameritas Investment Partners’s Apyx Medical APYX Stock Holding History

Ameritas Investment Partners’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,938	Closed	-$19K	–	3069
2022 Q1	$19K	Hold	2,938	–	–	﹤0.01%	2578
2021 Q4	$38K	Hold	2,938	–	–	﹤0.01%	2302
2021 Q3	$41K	Hold	2,938	–	–	﹤0.01%	2280
2021 Q2	$30K	Hold	2,938	–	–	﹤0.01%	2496
2021 Q1	$28K	Hold	2,938	–	–	﹤0.01%	2402
2020 Q4	$21K	Hold	2,938	–	–	﹤0.01%	2437
2020 Q3	$14K	Hold	2,938	–	–	﹤0.01%	2551
2020 Q2	$16K	Hold	2,938	–	–	﹤0.01%	2456
2020 Q1	$11K	Hold	2,938	–	–	﹤0.01%	2481
2019 Q4	$25K	Hold	2,938	–	–	﹤0.01%	2293
2019 Q3	$20K	Hold	2,938	–	–	﹤0.01%	2383
2019 Q2	$20K	Buy	+2,938	New	+$16K	﹤0.01%	2428

Other funds holding APYX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Ameritas Investment Partners's APYX Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 2,938 shares — an estimated $19K sold.

Ameritas Investment Partners first reported a position in APYX in Q2 2019 and held it in 12 quarters. The position peaked at $41K in Q3 2021. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

Ameritas Investment Partners reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 2,938 Apyx Medical shares in Q2 2022, an estimated $19K.
Ameritas Investment Partners first reported a position in Apyx Medical in Q2 2019 and held it in 12 quarters.
Ameritas Investment Partners's Apyx Medical position peaked at $41K in Q3 2021.
63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.